Lapatinib and retinoic acid combination treatment of SKBR3 breast cancer cells
Ontology highlight
ABSTRACT: SKBR3 cells, which bear both an HER2 and a RARA gene amplification, were treated for 12 or 48 hours with 100 nM retinoic acid, 100 nM lapatinib or the combination.The two drugs synergize and induce massive apoptosis. The aim is to find the molecular mechanism(s) of this synergism. Gene expression profiling was performed using Agilent two-color 4X44K arrays. Original processed data are available in the archive: http://www.ebi.ac.uk/arrayexpress/files/E-MEXP-3192/E-MEXP-3192.additional.zip
ORGANISM(S): Homo sapiens
SUBMITTER: Maddalena Fratelli
PROVIDER: E-MEXP-3192 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA